Hysterectomy and the Cardiometabolic Risk Signal Emerging from Observational Data
A new systematic review and meta-analysis links hysterectomy to a measurable rise in several major atherosclerotic cardiovascular disease risk factors. Across 20 included studies drawn from 18,337 screened records, hysterectomy tracked with higher rates of hypertension, diabetes, hyperlipidemia, obesity, and metabolic syndrome. The signal was consistent enough to appear across both cross-sectional and cohort evidence, which gives the finding more weight than any single study could provide.
The numbers are not subtle. For hypertension, the pooled cross-sectional odds ratio was 1.32 with a 95% confidence interval of 1.18 to 1.48, while the cohort hazard ratio was 1.19 with a 95% confidence interval of 1.09 to 1.30. Diabetes showed a similar pattern: the cross-sectional odds ratio reached 1.21, and the cohort hazard ratio reached 1.20. Hyperlipidemia carried a hazard ratio of 1.21, obesity an odds ratio of 1.24, and metabolic syndrome an odds ratio of 1.24. Those effect sizes are modest rather than dramatic, yet in cardiovascular prevention even modest shifts matter when they affect common exposures and lifelong risk.
One sentence captures the clinical weight of the findings: hysterectomy did not behave like a neutral gynecologic endpoint.
Why Removal of the Uterus May Alter Long-Term Vascular Biology
The association is biologically plausible. Hysterectomy can intersect with endocrine, metabolic, and vascular pathways in ways that extend beyond the operating room. If ovarian function is affected, even partially, downstream changes in estrogen signaling may influence lipid handling, insulin sensitivity, vascular tone, and central adiposity. Those pathways are tightly linked to atherogenesis, and they help explain why hypertension, dyslipidemia, diabetes, and metabolic syndrome appeared together rather than as isolated outcomes.
The review also points toward a broader systems-level issue: surgery performed earlier in reproductive life may expose patients to a longer interval during which altered metabolic risk can accumulate. A younger patient who enters the post-hysterectomy years with worse blood pressure, glycemic control, or body composition has more time for those risk factors to translate into arterial injury. The paper’s conclusion therefore lands on follow-up rather than treatment alone. Active cardiovascular risk assessment after hysterectomy, especially when the operation occurs at a young age, becomes a logical response to the observed associations.
What the Meta-Analysis Included and How the Evidence Was Built
Investigators searched PubMed, Cochrane Library, Embase, and ScienceDirect from database inception through March 10, 2026. Eligible studies included randomized controlled trials, case-control studies, cross-sectional studies, cohort studies, case series, and experimental studies if they reported new-onset cardiovascular events, diabetes, hypertension, dyslipidemia, or other metabolic effects after hysterectomy. Reviews and book chapters were excluded.
Study selection and data extraction were performed independently by multiple reviewers, with disagreements resolved by consensus. Cohort studies were rated with the Newcastle-Ottawa Scale, while a modified version was used for cross-sectional studies. Meta-analyses used a generic inverse-variance random-effects model, stratified by study design and by effect measure, including adjusted odds ratios, adjusted hazard ratios, and relative risks. Outcomes that did not meet criteria for quantitative synthesis were handled with narrative review.
This structure matters because a mixed literature can easily blur causation, timing, and outcome definitions. By separating cohort from cross-sectional estimates, the analysis allows readers to see where longitudinal risk aligns with point-prevalence associations and where design differences may temper interpretation.
A Consistent Pattern Across Hypertension, Diabetes, and Lipids
Hypertension emerged as one of the clearest signals, and that is clinically important because blood pressure is both common and modifiable. A woman whose vascular risk profile worsens after hysterectomy may not present with a single obvious complication; instead, the change may unfold through routine clinic measurements, an antihypertensive prescription, or a diagnosis of metabolic syndrome years later. Diabetes showed similar directionality, suggesting that insulin resistance or metabolic dysregulation may be part of the same post-surgical pattern rather than a separate finding.
Hyperlipidemia adds another layer. Elevated atherogenic lipids can accelerate plaque formation even when symptoms remain absent for long periods, and the hazard ratio of 1.21 suggests the risk increase is persistent rather than fleeting. Obesity and metabolic syndrome are especially relevant because they can compound one another, amplifying future coronary, cerebrovascular, and peripheral vascular risk. In bedside terms, the post-hysterectomy patient may need surveillance that is more deliberate than the usual opportunistic screening approach.
What Clinicians Should Do with a Preprint Like This
This is a preprint, so it has not yet passed peer review, and the findings should be treated as hypothesis-strengthening rather than practice-changing. Even so, the direction of the evidence is hard to ignore. Gynecologic surgery is often discussed in terms of bleeding, pain, adhesions, fertility, and recovery, yet this analysis suggests the downstream cardiometabolic consequences deserve equal attention.
The practical consequence is not a recommendation to avoid hysterectomy when it is indicated. It is a reminder that postoperative care should not stop at incision healing. Blood pressure, fasting glucose or diabetes surveillance, lipid status, body weight, and features of metabolic syndrome may deserve closer follow-up after surgery, particularly in younger women who have more years ahead for risk accumulation. When hysterectomy is performed in the setting of benign disease, that long tail of cardiovascular monitoring may be the part of care most likely to be overlooked.
The study leaves a few important questions unresolved. It does not establish causality, and the included designs cannot fully separate the effect of hysterectomy itself from the conditions that led to surgery, the status of the ovaries, or other unmeasured confounders. Even so, the pooled estimates point in one direction: hysterectomy is associated with a higher burden of major modifiable cardiovascular risk factors, and the aftermath deserves cardiovascular attention, not only surgical follow-up.